ABL Bio - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeABL Bio
ABL Bio logo

ABL Bio

0 followers

298380

Performance

About ABL Bio

ABL Bio is a biotech company specializing in developing innovative treatments for various diseases, including cancer and neurodegenerative disorders. They have a strong focus on developing immunotherapy and antibody-drug conjugate (ADC) treatments.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

South Korea

Founded

2016

Employees

51 - 200

Status

Investor

Investor Type

Corporate Investor

Website

https://ablbio.com